Global Huntington’s Disease Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3065

Medications for movement disorders. Drugs to treat movement disorders include the following: Tetrabenazine (Xenazine) is specifically approved by the Food and Drug Administration to suppress the involuntary jerking and writhing movements (chorea) associated with Huntington's disease.
Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipeline, rise in target population, and favorable government initiatives are some of the key factors contributing to market growth.
In 2018, the global Huntington’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Huntington’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Huntington’s Disease Treatment development in United States, Europe and China.

The key players covered in this study
Valeant Pharmaceuticals
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
...

Market segment by Type, the product can be split into
Symptomatic Therapy
Disease-Modifying Therapy

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Huntington’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Huntington’s Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Huntington’s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Huntington’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Symptomatic Therapy
1.4.3 Disease-Modifying Therapy
1.5 Market by Application
1.5.1 Global Huntington’s Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Huntington’s Disease Treatment Market Size
2.2 Huntington’s Disease Treatment Growth Trends by Regions
2.2.1 Huntington’s Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Huntington’s Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Huntington’s Disease Treatment Market Size by Manufacturers
3.1.1 Global Huntington’s Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Huntington’s Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Huntington’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Huntington’s Disease Treatment Key Players Head office and Area Served
3.3 Key Players Huntington’s Disease Treatment Product/Solution/Service
3.4 Date of Enter into Huntington’s Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Huntington’s Disease Treatment Market Size by Type (2014-2019)
4.2 Global Huntington’s Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Huntington’s Disease Treatment Market Size (2014-2019)
5.2 Huntington’s Disease Treatment Key Players in United States
5.3 United States Huntington’s Disease Treatment Market Size by Type
5.4 United States Huntington’s Disease Treatment Market Size by Application

6 Europe
6.1 Europe Huntington’s Disease Treatment Market Size (2014-2019)
6.2 Huntington’s Disease Treatment Key Players in Europe
6.3 Europe Huntington’s Disease Treatment Market Size by Type
6.4 Europe Huntington’s Disease Treatment Market Size by Application

7 China
7.1 China Huntington’s Disease Treatment Market Size (2014-2019)
7.2 Huntington’s Disease Treatment Key Players in China
7.3 China Huntington’s Disease Treatment Market Size by Type
7.4 China Huntington’s Disease Treatment Market Size by Application

8 Japan
8.1 Japan Huntington’s Disease Treatment Market Size (2014-2019)
8.2 Huntington’s Disease Treatment Key Players in Japan
8.3 Japan Huntington’s Disease Treatment Market Size by Type
8.4 Japan Huntington’s Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Huntington’s Disease Treatment Market Size (2014-2019)
9.2 Huntington’s Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Huntington’s Disease Treatment Market Size by Type
9.4 Southeast Asia Huntington’s Disease Treatment Market Size by Application

10 India
10.1 India Huntington’s Disease Treatment Market Size (2014-2019)
10.2 Huntington’s Disease Treatment Key Players in India
10.3 India Huntington’s Disease Treatment Market Size by Type
10.4 India Huntington’s Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Huntington’s Disease Treatment Market Size (2014-2019)
11.2 Huntington’s Disease Treatment Key Players in Central & South America
11.3 Central & South America Huntington’s Disease Treatment Market Size by Type
11.4 Central & South America Huntington’s Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Valeant Pharmaceuticals
12.1.1 Valeant Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Huntington’s Disease Treatment Introduction
12.1.4 Valeant Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.1.5 Valeant Pharmaceuticals Recent Development
12.2 Teva Pharmaceuticals
12.2.1 Teva Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Huntington’s Disease Treatment Introduction
12.2.4 Teva Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.2.5 Teva Pharmaceuticals Recent Development
12.3 Wave Life Sciences
12.3.1 Wave Life Sciences Company Details
12.3.2 Company Description and Business Overview
12.3.3 Huntington’s Disease Treatment Introduction
12.3.4 Wave Life Sciences Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.3.5 Wave Life Sciences Recent Development
12.4 Ionis Pharmaceuticals/ Roche
12.4.1 Ionis Pharmaceuticals/ Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Huntington’s Disease Treatment Introduction
12.4.4 Ionis Pharmaceuticals/ Roche Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.4.5 Ionis Pharmaceuticals/ Roche Recent Development
12.5 Raptor Pharmaceuticals
12.5.1 Raptor Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Huntington’s Disease Treatment Introduction
12.5.4 Raptor Pharmaceuticals Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.5.5 Raptor Pharmaceuticals Recent Development
12.6 Prana Biotechnology
12.6.1 Prana Biotechnology Company Details
12.6.2 Company Description and Business Overview
12.6.3 Huntington’s Disease Treatment Introduction
12.6.4 Prana Biotechnology Revenue in Huntington’s Disease Treatment Business (2014-2019)
12.6.5 Prana Biotechnology Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details